| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $122.3M | +24.7% |
| Cost of Revenue | $31.6M | +28.3% |
| Gross Profit | $90.7M | +23.5% |
| R&D Expense | $8.0M | +44.6% |
| SG&A Expense | $59.4M | +28.9% |
| Operating Income | -$25.4M | -40.9% |
| Pre-tax Income | -$3.7M | +78.8% |
| Income Tax | -$4.9M | -338.6% |
| Net Income | $1.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $109.3M | +138.1% |
| Accounts Receivable | $24.8M | +38.2% |
| Inventory | $78.2M | +35.8% |
| Current Assets | $226.7M | +69.6% |
| Total Assets | $427.7M | +40.6% |
| Current Liabilities | $30.9M | +3.9% |
| Long-term Debt | $907K | -13.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.8M | -66.6% |
| Capital Expenditures | $10.0M | +23.8% |
| Investing Cash Flow | -$113.4M | -1429.8% |
| Financing Cash Flow | $136.0M | — |
| Free Cash Flow | -$31.8M | -50.2% |
| +107.7% |
| EPS (Basic) | $0.06 | +107.1% |
| EPS (Diluted) | $0.06 | +107.1% |
| Total Liabilities |
| $49.1M |
| -37.8% |
| Stockholders' Equity | $378.6M | +68.0% |